ANNE ZWART: Open Payments
NPI 1679975544 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 29 payments from 15 companies in 2025. Trend: 2023 $370 · 2024 $502 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $189 |
| PFIZER INC. | 7 | $130 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Exact Sciences Corporation | 2 | $59 |
| ABBVIE INC. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
Products named: REXULTI, NURTEC ODT, ELIQUIS, Cologuard Collection Kit, Veozah, BREZTRI, TRELEGY ELLIPTA, NEXIUM.
Industry payments across MI — which companies pay providers there.
